尿路性心周炎和心脏吸血栓通过密集的血液透析来解决
Mayuri Patel1,2, Shiavax J Rao1,2, Abhinandan R Chittal1,2
1Medicine, MedStar Union Memorial Hospital, Baltimore, MD, USA.
概括
密集的血液透析 (HD) 有效地治疗了由尿性心周炎 (UP) 引起的心脏吸管. 这种方法应该是UP相关心周溢出的主要管理策略,根据患者的病情加剧的HD.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 尿路性心膜炎 (UP) 是慢性病的一种严重并发症.
- 在UP中心周输出可能导致心脏坦波纳德,这是一种危及生命的疾病.
- 目前对UP诱导心周溢血的管理策略各不相同.
研究的目的:
- 呈现出一个复杂的心脏坦波纳病例,是尿性心周炎的次要病例.
- 评估密集血液透析 (HD) 治疗这种疾病的有效性.
- 倡导HD作为一线治疗尿性心周炎与心周溢血的第一线治疗.
主要方法:
- 一个病人的病例报告,因为尿路性心周炎而导致心脏坦波纳.
- 治疗涉及密集的血液透析.
- 用临床表现和严重程度来指导治疗强化.
主要成果:
- 患者的心脏吸管完全通过密集的血液透析来解决.
- 血液透析被证明是一种有效的治疗方式,用于与尿性心周炎相关的心周溢出.
- 在密集的疾病治疗期间或之后,没有报告任何并发症.
结论:
- 密集型血液透析是一种高度有效的第一线治疗,用于尿路性心周炎引起的心脏坦普.
- 血液透析的治疗强化应根据个体患者的临床状况量身定制.
- 早期考虑血液透析可以防止需要更多的侵入性手术.
相关概念视频
Dialysis
288
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
288
Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419


